Cargando…
Genetic Variation in CYP3A43 Explains Racial Difference in Olanzapine Clearance
The antipsychotic drug, olanzapine, one of the most widely used drugs in clinical medicine, has a high rate of discontinuation due to inefficacy and/or adverse effects. We identified a SNP in the drug metabolizing enzyme cytochrome, P450 3A43 (CYP3A43; rs472660) that highly significantly predicted o...
Autores principales: | Bigos, Kristin L., Bies, Robert R., Pollock, Bruce G., Lowy, Joshua J., Zhang, Fengyu, Weinberger, Daniel R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100476/ https://www.ncbi.nlm.nih.gov/pubmed/21519338 http://dx.doi.org/10.1038/mp.2011.38 |
Ejemplares similares
-
Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine
por: Khusial, Richard, et al.
Publicado: (2023) -
Unpacking the Racial Gap: Helicobacter pylori Infection Clearance Among Different Racial Groups
por: Rammohan, Rajmohan, et al.
Publicado: (2023) -
CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients
por: Fekete, Ferenc, et al.
Publicado: (2023) -
A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children
por: Brussee, Janneke M., et al.
Publicado: (2019) -
Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities
por: Non, Amy L., et al.
Publicado: (2021)